Recital 40, Regulation (EU) 2026/1826

In forcesince 28 Jul 2026

Applications for the respective renewals of the approval of the active substances amisulbrom, Bacillus amyloliquefaciens strain MBI 600, cyantraniliprole, isofetamid and S-abscisic acid were submitted and are being evaluated in accordance with Commission Implementing Regulation (EU) 2020/1740 [Commission Implementing Regulation (EU) 2020/1740 of 20 November 2020 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and repealing Commission Implementing Regulation (EU) No 844/2012 (OJ L 392, 23.11.2020, p. 20, ELI: http://data.europa.eu/eli/reg_impl/2020/1740/oj).].